This announcement is a separate document:
武田薬品工業：（訂正）2024年3月31日に終了した事業年度（IFRS、連結）の財務諸表の要約の一部訂正
Takeda Pharmaceutical: (Correction) Partial correction to the summary of financial statements for the fiscal year ended 2024/3/31 (IFRS, consolidated)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.